Erythromycin Phthalic acid adduct

Status: In-stock

It is one of impurity present in Erythromycin, Erythromycin is a bacteriostatic antibiotic, that acts by inhibiting protein synthesis by binding to ribosomal RNA. It stops bacterial protein synthesis by inhibiting the transpeptidation of protein synthesis and by inhibiting the assembly of the 50S ribosomal subunit. which results in the control of various bacterial infections, and also causes hepatic dysfunction, cholestatic jaundice, and abnormal liver transaminases.

Request quotation

Additional information on Erythromycin Phthalic acid adduct

Catalogue No. VE009694
Molecular Formula C45H73NO17
Molecular Weight 900.06 g/mol
Parent drug Erythromycin
IUPAC Name (3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-6-(((2S, 3R, 4S, 6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7, 12, 13-trihydroxy-4-(((2R, 4R, 5S, 6S)-5-hydroxy-4-methoxy-4, 6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3, 5, 7, 9, 11, 13-hexamethyloxacyclotetradecane-2, 10-dione phthalate
Synonyms N/A
References Khashayar Farzam, Nessel, T. A., & Quick, J. (2022, June 16). Erythromycin. Retrieved November 1, 2022, from website:
Status In-stock

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

Erythromycin Phthalic acid adduct

"*" indicates required fields

Products quotation
This field is for validation purposes and should be left unchanged.